Reference
Trumbo H, et al. Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System. Drug Safety 44: 107-119, No. 1, Jan-Mar 2021. Available from: URL: http://doi.org/10.1007/s40264-020-01022-2
Rights and permissions
About this article
Cite this article
Antianaemics. Reactions Weekly 1849, 40 (2021). https://doi.org/10.1007/s40278-021-93424-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-93424-6